SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-117969
Filing Date
2024-04-26
Accepted
2024-04-26 16:05:30
Documents
3
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d746513ddef14a.htm DEF 14A 648629
2 GRAPHIC g746513dsp004.jpg GRAPHIC 239193
3 GRAPHIC g746513dsp005.jpg GRAPHIC 119766
  Complete submission text file 0001193125-24-117969.txt   1137037
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39247 | Film No.: 24883544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)